Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Role of Bacterial and Fungal Human Respiratory Microbiota in Covid-19 Patients Publisher Pubmed



Soltani S1, 2 ; Zakeri A3 ; Zandi M1 ; Kesheh MM4 ; Tabibzadeh A4 ; Dastranj M5 ; Faramarzi S6 ; Didehdar M7 ; Hafezi H8 ; Hosseini P1 ; Farahani A5
Authors

Source: BioMed Research International Published:2021


Abstract

Recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), has led to a worldwide pandemic with millions of infected patients. Alteration in humans' microbiota was also reported in COVID-19 patients. The alteration in human microbiota may contribute to bacterial or viral infections and affect the immune system. Moreover, human's microbiota can be altered due to SARS-CoV-2 infection, and these microbiota changes can indicate the progression of COVID-19. While current studies focus on the gut microbiota, it seems necessary to pay attention to the lung microbiota in COVID-19. This study is aimed at reviewing respiratory microbiota dysbiosis among COVID-19 patients to encourage further studies on the field for assessment of SARS-CoV-2 and respiratory microbiota interaction. © 2021 Saber Soltani et al.
1. Gut Microbiota and Covid-19: A Systematic Review, Health Science Reports (2023)
2. Gut Microbiota Might Act As a Potential Therapeutic Pathway in Covid-19, Current Pharmaceutical Biotechnology (2022)
3. Effect of Probiotics on Covid-19 Infection: A Systematic Review, Scientific Journal of Kurdistan University of Medical Sciences (2024)
Experts (# of related papers)